C
CorMedix Inc. (CRMD)
NGM – Real vaqt narxi. Valyuta: USD
7.51
-0.15 (-1.96%)
Yopilishda: May 12, 2026, 4:00 PM EDT
7.44
-0.07 (-0.93%)
Bozor oldidan: May 13, 2026, 7:00 AM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NGM – Real vaqt narxi. Valyuta: USD
7.51
-0.15 (-1.96%)
Yopilishda: May 12, 2026, 4:00 PM EDT
7.44
-0.07 (-0.93%)
Bozor oldidan: May 13, 2026, 7:00 AM EDT
CorMedix Inc., biofarmatsevtika kompaniyasi, Qo'shma Shtatlarda hayot uchun xavfli kasalliklar va sharoitlarni davolash uchun terapevtik mahsulotlarni ishlab chiqish va tijoratlashtirishga qaratilgan. Uning etakchi mahsulot nomzodi DefenCath bo'lib, bu katteter bilan bog'liq qon oqimi infektsiyalari bilan kasallangan buyrak etishmovchiligi bo'lgan kattalar bemorlarda ushbu infektsiyalar sonini kamaytirishga mo'ljallangan antimikrobial katteter blokirovka eritmasidir. CorMedix Inc. ilgari Picton Holding Company, Inc. nomi bilan tanilgan va 2007 yil yanvar oyida CorMedix, Inc. nomini o'zgartirgan. Kompaniya 2006 yilda ro'yxatga olingan va Nyu-Jersi shtatining Parsippany shahrida joylashgan.
| Ism | Lavozim |
|---|---|
| Donna Ucci | Senior VP & Head of Global Quality |
| Dr. Matthew T. David M.D. | EVP & Chief Business Officer |
| Dr. Peter Sullivan BCOP, Pharm.D. | Senior Vice President of Market Access |
| Dr. Tushar Mukherjee | Senior VP & Head of Technical Operations |
| Mr. Joseph Todisco MBA | CEO & Chairman of the Board of Directors |
| Mr. Michael Seckler | EVP & Chief Commercial Officer |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-04-29 | DEFA14A | ea0286136-04.htm |
| 2026-04-27 | 8-K | ea0287640-8k_cormedix.htm |
| 2026-04-17 | PRE 14A | ea0286136-02.htm |
| 2026-03-06 | 8-K | ea0280394-8k_cormedix.htm |
| 2026-03-05 | 8-K | ea027968001-8k_cormedix.htm |
| 2026-03-05 | 10-K | ea0278169-10k_cormedix.htm |
| 2026-01-08 | 8-K | ea0272149-8k_cormedix.htm |
| 2025-11-13 | S-8 | ea0264891-s8_cormedix.htm |
| 2025-11-12 | 10-Q | ea0264325-10q_cormedix.htm |
| 2025-10-24 | DEF 14A | ea0261891-01.htm |
| Ms. Beth Steinbrenner | SVP & Chief Human Resource Officer |
| Ms. Elizabeth Masson-Hurlburt B.A. | Executive VP, Chief Operating Officer & Chief Integration Officer |
| Ms. Kaufman Beth Zelnick Esq. | EVP, Chief Legal and Compliance Officer & Corporate Secretary |
| Ms. Susan Blum | EVP & Chief Financial Officer |